Overall, LIF plays an important pathophysiological role in cancer and cardiovascular diseases, and may be considered as a new inflammatory biomarker to monitor the status of tumor progression and underlying cardiovascular damage in NSCLC patients. The gene discussed is LIF; the disease is cardiovascular disorder.